HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julio Coll Selected Research

guanylyl-(3'-5')-guanosine

1/2018Rainbow Trout Erythrocytes ex vivo Transfection With a DNA Vaccine Encoding VHSV Glycoprotein G Induces an Antiviral Immune Response.
1/2013Increasing versatility of the DNA vaccines through modification of the subcellular location of plasmid-encoded antigen expression in the in vivo transfected cells.
6/2011Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julio Coll Research Topics

Disease

17Infections
05/2019 - 09/2008
8Virus Diseases (Viral Diseases)
01/2019 - 01/2013
7Viremia
03/2019 - 01/2013
6Hemorrhagic Septicemia (Haemorrhagic Septicemia)
01/2018 - 09/2010
3Bacterial Infections (Bacterial Infection)
01/2021 - 11/2017
3Inflammation (Inflammations)
01/2019 - 01/2017
3Necrosis
01/2018 - 01/2008
3Viral Hemorrhagic Septicemia
01/2017 - 06/2011
1Premature Aging
10/2019
1Coronary Disease (Coronary Heart Disease)
11/2017
1Hemorrhage
11/2015

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2019 - 09/2010
6Antiviral Agents (Antivirals)IBA
01/2019 - 02/2013
5Glycoproteins (Glycoprotein)IBA
01/2018 - 06/2011
4DNA VaccinesIBA
01/2018 - 01/2013
3CytokinesIBA
01/2019 - 01/2008
3guanylyl-(3'-5')-guanosineIBA
01/2018 - 06/2011
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
2Immunoglobulin M (IgM)IBA
05/2019 - 03/2013
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2014
2InterferonsIBA
01/2018 - 01/2017
2Poly I-CIBA
09/2017 - 09/2008
2VaccinesIBA
03/2013 - 09/2010
1AntioxidantsIBA
10/2019
1navitoclaxIBA
10/2019
1Acetylcarnitine (Alcar)IBA
10/2019
1Blood Proteins (Serum Proteins)IBA
03/2019
1Vitellogenins (Vitellogenin)IBA
03/2019
1LipidsIBA
01/2019
125-hydroxycholesterolIBA
01/2019
1histone H3 trimethyl Lys4IBA
11/2018
1ChromatinIBA
11/2018
1Histones (Histone)IBA
11/2018
1Viral ProteinsIBA
01/2018
1ZymosanIBA
01/2018
1GlucansIBA
01/2018
1beta-GlucansIBA
01/2018
1LipopolysaccharidesIBA
09/2017
1FicollIBA
01/2017
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1Conditioned Culture MediaIBA
01/2017
1SerpinsIBA
11/2015
1Peptides (Polypeptides)IBA
11/2015
1Tannic AcidFDA Link
11/2015
1tiplaxtininIBA
11/2015
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015
1Mitogen-Activated Protein KinasesIBA
01/2015
1Epidermal Growth Factor (EGF)IBA
01/2015
1Neutralizing AntibodiesIBA
11/2013
1AntibodiesIBA
03/2013
1Monoclonal AntibodiesIBA
02/2013
1Melitten (Melittin)IBA
02/2013
1Pharmaceutical PreparationsIBA
01/2013
1Viral RNAIBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Complement System Proteins (Complement)IBA
09/2010
1Differentiation AntigensIBA
09/2010
1Histocompatibility Antigens Class IIBA
09/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
1Interleukin-8 (Interleukin 8)IBA
01/2008